Quantum-Si Incorporated Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
19.8%projected annual EPS growth
Analyst Coverage
3analysts covering
FY EPS (est.)
-$0.40next fiscal year
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q3 2026 Earnings Release | 5 Nov 2026 |
Monitoring Framework
Key Performance Indicators
Proteus Amino Acid Detection Capability Quarterly17.0Target: 18 amino acids at launch, 20 amino acids demonstrated during 2026
Quarterly Revenue Quarterly258KTarget: Approximately $1.0 million for full year 2026
Cash, Cash Equivalents, and Marketable Securities Quarterly190.4MTarget: Sufficient runway to support operations into Q2 2028
Watch Items
- Proteus Commercial Launch TimelineTrigger: Delay of commercial launch beyond late 2026Action: Re-evaluate cash runway projections and adjust operating expense guidance.
- Consumables Revenue MixTrigger: Gross margin falling below 25% due to unfavorable hardware/consumables mixAction: Review pricing strategy for Platinum kits and initial Proteus pre-orders.
Research as of 20 Jun 2026